Agilent Technologies will replace Lion Bioscience as a partner in an $11.7 million National Institute of Standards and Technology advanced technology grant project managed by Icoria, formerly known as Paradigm Genetics.

NIST approved Agilent after Lion withdrew from participation. The grant is designed to develop informatics applications for discovering and validating drug-development targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.